# Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Study · id `cardio:ct-nct04437303` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04437303](<https://clinicaltrials.gov/study/NCT04437303>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04437303

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Valve and congenital heart disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 858 participants.

## Technical summary

Registry record NCT04437303. Randomized; single masking; primary purpose prevention. Start 2020-11-25 (actual); primary completion 2024-03-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 858 participants (enrolled count; ClinicalTrials.gov record NCT04437303, source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)
- Started: 2020-11-25 (actual) (ClinicalTrials.gov record NCT04437303, source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)
- Primary completion: 2024-03-21 (actual) (ClinicalTrials.gov record NCT04437303, source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)
- Completion: 2024-05-22 (actual) (ClinicalTrials.gov record NCT04437303, source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)
- Countries: Belgium; Denmark; Ireland; Italy; Luxembourg; Netherlands (ClinicalTrials.gov record NCT04437303, source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04437303-2024-05-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
- Condition: Aortic Valve Disease
- Condition: Aortic Valve Stenosis
- Condition: Stroke
- Condition: Bleeding
- Condition: Vascular Complications
- Condition: Myocardial Infarction
- Condition: Thrombosis Embolism
- Intervention (Drug): Continuation of oral anticoagulants
- Intervention (Drug): Interruption of oral anticoagulants
- Lead sponsor: St. Antonius Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: St. Antonius Hospital (`cardio:org-st-antonius-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Continuation versus Interruption of Oral Anticoagulation during TAVI (`cardio:pubmed-39216096`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c860bf9732ed5a2131b89b29f0bbbe6cfdfc8f3b121088a3122d771bc6a40d80
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
